Literature DB >> 23736301

Mitochondrial damage revealed by immunoselection for ALS-linked misfolded SOD1.

Sarah Pickles, Laurie Destroismaisons, Sarah L Peyrard, Sarah Cadot, Guy A Rouleau, Robert H Brown, Jean-Pierre Julien, Nathalie Arbour, Christine Vande Velde.   

Abstract

Mutant superoxide dismutase 1 (SOD1) selectively associates with spinal cord mitochondria in rodent models of SOD1-mediated amyotrophic lateral sclerosis. A portion of mutant SOD1 exists in a non-native/misfolded conformation that is selectively recognized by conformational antibodies. Misfolded SOD1 is common to all mutant SOD1 models, is uniquely found in areas affected by the disease and is considered to mediate toxicity. We report that misfolded SOD1 recognized by the antibody B8H10 is present in greater abundance in mitochondrial fractions of SOD1(G93A) rat spinal cords compared with oxidized SOD1, as recognized by the C4F6 antibody. Using a novel flow cytometric assay, we detect an age-dependent deposition of B8H10-reactive SOD1 on spinal cord mitochondria from both SOD1(G93A) rats and SOD1(G37R) mice. Mitochondrial damage, including increased mitochondrial volume, excess superoxide production and increased exposure of the toxic BH3 domain of Bcl-2, tracks positively with the presence of misfolded SOD1. Lastly, B8H10 reactive misfolded SOD1 is present in the lysates and mitochondrial fractions of lymphoblasts derived from ALS patients carrying SOD1 mutations, but not in controls. Together, these results highlight misfolded SOD1 as common to two ALS rodent animal models and familial ALS patient lymphoblasts with four different SOD1 mutations. Studies in the animal models point to a role for misfolded SOD1 in mitochondrial dysfunction in ALS pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23736301      PMCID: PMC5052069          DOI: 10.1093/hmg/ddt249

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  56 in total

1.  Amyotrophic lateral sclerosis is a non-amyloid disease in which extensive misfolding of SOD1 is unique to the familial form.

Authors:  Aaron Kerman; Hsueh-Ning Liu; Sidney Croul; Juan Bilbao; Ekaterina Rogaeva; Lorne Zinman; Janice Robertson; Avijit Chakrabartty
Journal:  Acta Neuropathol       Date:  2010-01-29       Impact factor: 17.088

2.  Mitochondrial alterations in the spinal cord of patients with sporadic amyotrophic lateral sclerosis.

Authors:  Shoichi Sasaki; Makoto Iwata
Journal:  J Neuropathol Exp Neurol       Date:  2007-01       Impact factor: 3.685

3.  AMPA exposures induce mitochondrial Ca(2+) overload and ROS generation in spinal motor neurons in vitro.

Authors:  S G Carriedo; S L Sensi; H Z Yin; J H Weiss
Journal:  J Neurosci       Date:  2000-01-01       Impact factor: 6.167

4.  An over-oxidized form of superoxide dismutase found in sporadic amyotrophic lateral sclerosis with bulbar onset shares a toxic mechanism with mutant SOD1.

Authors:  Stefania Guareschi; Emanuela Cova; Cristina Cereda; Mauro Ceroni; Elena Donetti; Daryl A Bosco; Davide Trotti; Piera Pasinelli
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-13       Impact factor: 11.205

5.  Misfolded mutant SOD1 directly inhibits VDAC1 conductance in a mouse model of inherited ALS.

Authors:  Adrian Israelson; Nir Arbel; Sandrine Da Cruz; Hristelina Ilieva; Koji Yamanaka; Varda Shoshan-Barmatz; Don W Cleveland
Journal:  Neuron       Date:  2010-08-26       Impact factor: 17.173

6.  Effect of Bcl-2 overexpression on mitochondrial structure and function.

Authors:  Alicia J Kowaltowski; Ricardo G Cosso; Claudia B Campos; Gary Fiskum
Journal:  J Biol Chem       Date:  2002-08-30       Impact factor: 5.157

7.  A novel monoclonal antibody reveals a conformational alteration shared by amyotrophic lateral sclerosis-linked SOD1 mutants.

Authors:  Takao Fujisawa; Kengo Homma; Namiko Yamaguchi; Hisae Kadowaki; Naomi Tsuburaya; Isao Naguro; Atsushi Matsuzawa; Kohsuke Takeda; Yuji Takahashi; Jun Goto; Shoji Tsuji; Hideki Nishitoh; Hidenori Ichijo
Journal:  Ann Neurol       Date:  2012-11       Impact factor: 10.422

8.  Copper-binding-site-null SOD1 causes ALS in transgenic mice: aggregates of non-native SOD1 delineate a common feature.

Authors:  Jiou Wang; Hilda Slunt; Victoria Gonzales; David Fromholt; Michael Coonfield; Neal G Copeland; Nancy A Jenkins; David R Borchelt
Journal:  Hum Mol Genet       Date:  2003-09-09       Impact factor: 6.150

9.  Toxicity of familial ALS-linked SOD1 mutants from selective recruitment to spinal mitochondria.

Authors:  Jian Liu; Concepción Lillo; P Andreas Jonsson; Christine Vande Velde; Christopher M Ward; Timothy M Miller; Jamuna R Subramaniam; Jeffery D Rothstein; Stefan Marklund; Peter M Andersen; Thomas Brännström; Ole Gredal; Philip C Wong; David S Williams; Don W Cleveland
Journal:  Neuron       Date:  2004-07-08       Impact factor: 17.173

10.  Toxicity from different SOD1 mutants dysregulates the complement system and the neuronal regenerative response in ALS motor neurons.

Authors:  Christian S Lobsiger; Séverine Boillée; Don W Cleveland
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-26       Impact factor: 11.205

View more
  32 in total

Review 1.  RNA-targeted Therapeutics for ALS.

Authors:  Linga V Reddy; Timothy M Miller
Journal:  Neurotherapeutics       Date:  2015-04       Impact factor: 7.620

Review 2.  Regulation of mitophagy by the ubiquitin pathway in neurodegenerative diseases.

Authors:  Shyamal Desai; Meredith Juncker; Catherine Kim
Journal:  Exp Biol Med (Maywood)       Date:  2018-01-09

3.  Misfolded SOD1 is not a primary component of sporadic ALS.

Authors:  Sandrine Da Cruz; Anh Bui; Shahram Saberi; Sandra K Lee; Jennifer Stauffer; Melissa McAlonis-Downes; Derek Schulte; Donald P Pizzo; Philippe A Parone; Don W Cleveland; John Ravits
Journal:  Acta Neuropathol       Date:  2017-02-28       Impact factor: 17.088

Review 4.  Role of mitochondria in mutant SOD1 linked amyotrophic lateral sclerosis.

Authors:  Wenzhi Tan; Piera Pasinelli; Davide Trotti
Journal:  Biochim Biophys Acta       Date:  2014-02-22

Review 5.  Environmental exposure and mitochondrial epigenetics: study design and analytical challenges.

Authors:  Hyang-Min Byun; Andrea A Baccarelli
Journal:  Hum Genet       Date:  2014-01-09       Impact factor: 4.132

6.  Immunodetection of outer membrane proteins by flow cytometry of isolated mitochondria.

Authors:  Sarah Pickles; Nathalie Arbour; Christine Vande Velde
Journal:  J Vis Exp       Date:  2014-09-18       Impact factor: 1.355

7.  Stage-dependent remodeling of projections to motor cortex in ALS mouse model revealed by a new variant retrograde-AAV9.

Authors:  Barbara Commisso; Lingjun Ding; Karl Varadi; Martin Gorges; David Bayer; Tobias M Boeckers; Albert C Ludolph; Jan Kassubek; Oliver J Müller; Francesco Roselli
Journal:  Elife       Date:  2018-08-23       Impact factor: 8.140

8.  TNF receptor-associated factor 6 interacts with ALS-linked misfolded superoxide dismutase 1 and promotes aggregation.

Authors:  Sabrina Semmler; Myriam Gagné; Pranav Garg; Sarah R Pickles; Charlotte Baudouin; Emeline Hamon-Keromen; Laurie Destroismaisons; Yousra Khalfallah; Mathilde Chaineau; Elise Caron; Andrew N Bayne; Jean-François Trempe; Neil R Cashman; Alexandra T Star; Arsalan S Haqqani; Thomas M Durcan; Elizabeth M Meiering; Janice Robertson; Nathalie Grandvaux; Steven S Plotkin; Heidi M McBride; Christine Vande Velde
Journal:  J Biol Chem       Date:  2020-02-06       Impact factor: 5.157

9.  Opposite Synaptic Alterations at the Neuromuscular Junction in an ALS Mouse Model: When Motor Units Matter.

Authors:  Elsa Tremblay; Éric Martineau; Richard Robitaille
Journal:  J Neurosci       Date:  2017-08-11       Impact factor: 6.167

10.  Endogenous macrophage migration inhibitory factor reduces the accumulation and toxicity of misfolded SOD1 in a mouse model of ALS.

Authors:  Marcel F Leyton-Jaimes; Clara Benaim; Salah Abu-Hamad; Joy Kahn; Amos Guetta; Richard Bucala; Adrian Israelson
Journal:  Proc Natl Acad Sci U S A       Date:  2016-08-22       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.